直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Advised a global healthcare company in anticipated court proceedings seeking declarations of non-infringement related to its influenza vaccines*

Advised a global healthcare company in anticipated court proceedings seeking declarations of non-infringement related to its influenza vaccines.

Related Professionals

Jin Ooi
Partner
London
+44 20 7864 2821
Email

Related Practices

Global IP Enforcement, Litigation, and Trials

Patent Litigation and Trials

Related Industries

Life Sciences

Pharmaceutical

Biologics

*Matter handled prior to joining Finnegan.

Related Experiences

Advised a global life sciences company on (non-)infringement issues relating to a chemistry-related patent covering an anti-cancer drug for treating leukemias*

Represented Japanese company in several patent infringement proceedings related to biochemistry technology*

Represented U.S. company in series of nullity and infringement proceedings related to consumer products*

Represented Japanese company in patent infringement and nullity proceedings related to LED-technology*

Advised a global healthcare company on supplementary protection certificate (SPC) protection covering a small molecule medicine for treating leukemia*

Advised a global innovator pharma company in relation to enforcement issues surrounding its second medical use patent for a chemotherapy medication*

Advised a global pharma company on loss of exclusivity and enforcement strategy in relation to its platelet inhibitor drug*

Advised a pulmonary drug delivery company on (non-)infringement issues relating to inhalers*

Advised on a trade mark infringement and passing off dispute relating to a global broadcaster at the High Court and validity dispute at the UKIPO*

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP